Daniel Lim

Daniel Lim is a professional with a unique blend of expertise in science, particularly biochemistry, and law, focusing on the intersection between intellectual property and innovation.

He has been recognized for his achievements in the legal field, including being listed as a WIPR Leader 2020 and earning Rising Star distinctions in various prestigious awards.

Daniel specializes in managing loss of exclusivity events in the life sciences sector, with a particular emphasis on challenges related to 'second medical use' patents.

His experience in groundbreaking cases like the Lyrica case highlights his proactive approach in navigating complex legal landscapes.

He advocates for a balanced approach in intellectual property rights, ensuring fair protection for genuine inventions while avoiding hindrances posed by excessive patents.

Daniel's interests extend to new and disruptive technologies like artificial intelligence, synthetic biology, and quantum computing, emphasizing the importance of understanding their societal impact and legal implications.

He is actively involved in professional organizations such as EPLAW and AIPPI, holding significant roles in committees related to biotechnology, intellectual property, and genetic resources.

Beyond his legal career, Daniel enjoys sports and music, with notable performances in leading roles in theater productions.